Regarding serum levels comparison within the different groups, increased levels of IL-6 were noted in patients with neural pain secondary to leprosy and type II diabetes mellitus in combination with neuropathic pain, indicating that IL-6 may be a pain biomarker. Here, IL6 is linked to type 2 diabetes mellitus.